Related Experiment Video
Updated: Jun 15, 2026
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial
Daniel Hinkerohe1, Dirk Smikalla, Andreas Schoebel
1Department of Neuroanatomy and Molecular Brain Research, Ruhr- University Bochum, Universitätsstrasse 150, 44780 Bochum, Germany. hinkerohe2@freenet.de
Abstract:
We analyzed the effect of dexamethasone on gram-negative bacteria derived lipopolysaccharide (LPS) induced inflammation in astroglial/microglial co-cultures. At the cellular level the microglial phenotype converted to an activated type after LPS incubation. Furthermore, LPS compromised functional astroglial properties like membrane resting potential, intracellular coupling and connexin 43 (Cx43) expression. This change in Cx43 expression was not due to a downregulation of Cx43 mRNA expression. Morphological and functional changes were accompanied by a time-dependent release of inflammation related cytokines. Co-incubation of dexamethasone with LPS prevented these LPS-induced changes within our glial co-culture model. The ability of dexamethasone to reconstitute astrocytic properties and to decrease microglial activation in vitro could be one possible explanation for the beneficial effects of dexamethasone in the treatment of acute bacterial meningitis in vivo.
Insights
Dexamethasone counters lipopolysaccharide (LPS)-induced inflammation in glial cells by preventing microglial activation and restoring astroglial function. This suggests dexamethasone’s potential benefit in treating bacterial meningitis.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Bacterial meningitis involves inflammation in glial cells, particularly microglia and astrocytes.
- Lipopolysaccharide (LPS) from gram-negative bacteria triggers this inflammatory response.
- Dexamethasone is used to treat bacterial meningitis, but its cellular mechanisms are not fully understood.
Purpose of the Study:
- To investigate the effects of dexamethasone on LPS-induced inflammation in astroglial/microglial co-cultures.
- To determine if dexamethasone can prevent LPS-induced changes in glial cell function and phenotype.
Main Methods:
- Co-culture of astroglial and microglial cells.
- Incubation with lipopolysaccharide (LPS) to induce inflammation.
- Treatment with dexamethasone in combination with LPS.
- Assessment of microglial activation, astroglial properties (membrane potential, coupling, connexin 43 expression), and cytokine release.
Main Results:
- LPS induced microglial activation and compromised astroglial function, including reduced connexin 43 (Cx43) expression, without altering Cx43 mRNA levels.
- LPS triggered a time-dependent release of inflammatory cytokines.
- Dexamethasone co-incubation prevented LPS-induced microglial activation and restored astroglial properties.
- Dexamethasone reduced the release of inflammatory cytokines.
Conclusions:
- Dexamethasone effectively counteracts LPS-induced inflammation in a glial co-culture model.
- The drug reconstitutes astrocytic functions and decreases microglial activation in vitro.
- These findings provide a cellular basis for the therapeutic benefits of dexamethasone in acute bacterial meningitis.
